Clinuvel Pharmaceuticals Limited Current Cash

Clinuvel Pharmaceuticals Limited (CLVLF) currently reports a current cash of $36M as of December 2025. That compares with $17M in the prior-year period — up 114.6% year over year. Use the charts on this page to explore Clinuvel Pharmaceuticals Limited's current cash history and peer comparisons.

Clinuvel Pharmaceuticals Limited's current cash increased from $17M to $36M — a 114.6% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clinuvel Pharmaceuticals Limited reported $36M in current cash as of December 2025. That compares with $17M in the prior-year period — up 114.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clinuvel Pharmaceuticals Limited, and consider following CLVLF for alerts when major investors trade the stock.

Clinuvel Pharmaceuticals Limited is classified in the Healthcare sector. On current cash, it currently shows $36M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLVLF with unrelated industries.